Overview Prandial Insulin Dosing in Hospitalized Patients Status: Completed Trial end date: 2013-03-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether mealtime insulin results in better control of blood sugar than a fixed meal dose in hospitalized patients. Phase: Phase 4 Details Lead Sponsor: Kathleen DunganCollaborator: Novo Nordisk A/STreatments: InsulinInsulin AspartInsulin degludec, insulin aspart drug combinationInsulin, Long-Acting